Nuformix forms nervous system disease pact with VistaGen Therapeutics
Pharmaceutical development company Nuformix said it had formed an agreement with VistaGen Therapeutics to develop treatments for central nervous system (CNS) diseases including depression.
The...
Wed, 27/05/2020 - 09:57